Ophthalmology

Obesity, overweight, and hypertension could also affect the risk of retinopathy if not managed in patients.

Patients with dry eye associated with contact lenses had significant improvement in visual acuity and their Ocular Surface Disease Index (OSDI) score after a month of using hydrogen peroxide.

Women who had children had a higher risk of reaching a visual acuity below 6/24 compared with those who did not have children.

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a look at recent research related to diabetic eye diseases.

Patients with amblyopia had a statistically significant improvement in their visual acuity after binocular rehabilitation through digital video games.

Glaucoma risk can be managed more effectively with the ability to use polygenic risk scores to identify individuals who can benefit from more intense treatment.

Atsena Therapeutics and Nippon Shinyaku have formed an exclusive licensing agreement for ATSN-101, a gene therapy for Leber congenital amaurosis (LCA1). Nippon Shinyaku will commercialize ATSN-101 in the US and Japan, while Atsena retains global rights outside these territories.

Polygenic risk score was valuable in enhancing risk prediction models for primary open-angle glaucoma (POAG.

Reduced well-being and loss of productivity were contributors to the high economic burden in patients with late-stage age-related macular degeneration (AMD) living in the US, Germany, and Bulgaria.

A machine-learning model developed in this study was able to predict 24-hour peaks for intraocular pressure (IOP).

Despite the incidence of retinoblastoma remaining consistent throughout Europe, different countries had differing rates of survival.

The suggestive evidence should encourage research into the associations to evaluate the association with stronger evidence.

Interventions to diagnosis amblyopia earlier could help in addressing inequities in the resolution of amblyopia.

Emotional and social support for patients with retinitis pigmentosa could reduce the incidence of depressive disorder in this demographic.

MYL-1701P displayed similar efficacy, safety, and immunogenicity when compared with reference aflibercept to treat diabetic macular edema.

An AI segmentation system was able to identify changes in retinal segmented features based on optical coherence tomography (OCT) images.

Treating and preventing correctable vision impairments could prevent up to 19% of dementia prevalence, according to a new study.

Primary care clinics in underserved areas including eye disease detection programs could reduce vision loss in the US.

A new study has found that prior authorizations for anti–vascular endothelial growth factor treatment led to a delay in patient care for most patients.

Mina Massaro-Giordano, MD, discussed the ways that dry eye can affect patients with the condition, as well as what symptoms can fly under the radar.

Patients with age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion can use faricimab-svoa as a prefilled syringe (PFS).

Adult patients with dry eye revealed their different challenges and experiences when living with the disease.

Patients with dry eye disease can be distinguished from patients with healthy eyes using a new artificial intelligence tool.

Incidence of postoperative endophthalmitis was low when patients were treated with either 1% povidone iodine disinfection with intracameral antibiotics or 5% povidone iodine with antibiotics.

A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence.

Expanding ways to treat eye pain could reduce the burden on the emergency department (ED) and other areas of the health care system.

Associations between ambient air pollutants and dry eye could have been mitigated during the pandemic.

An aflibercept dose of 4 mg for macular degeneration was found to reduce both central macular thickness and pigmental epithelium detachment for a longer duration compared with the 2 mg dose.

The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). However, patent litigation has left it unclear when the biosimilars will come to market.

An intravitreal ranibizumab injection was able to improve retinal sensitivity and thickness along with improving visual acuity.